European Society of Cardiology recommendations and practice for patients with NSTE-ACS and cardiogenic shock: the perks of cangrelor

Sponsored by Chiesi Farmaceutici
Other coronary interventions
Coronary Interventions
Focus on Drugs and Devices Synergy

Join us if you want

  • To learn about European Society of Cardiology recommendations for NSTE-ACS patients antithrombotic therapy and new survey data on real-world European scenario
  • To learn about European Society of Cardiology recommendations and practice in cardiogenic shock and out-of-hospital cardiac arrest patients antithrombotic therapy focusing on parenteral options
  • To discuss related real-world clinical cases of cangrelor use

Anchorperson: Davide Capodanno

Moderator: Dominick Angiolillo

Discussants: Giuseppe Musumeci, David Erlinge

Chatmaster: Francesco Costa

Session objectives

Davide Capodanno

Overview of the main data and characteristics of cangrelor

Dominick Angiolillo

READAPT survey - Introduction

Davide Capodanno

Case presentation

Giuseppe Musumeci

Recommendations and practice for patients with NSTE-ACS

Giuseppe Musumeci

Clinical case conclusion - Patient peri-PCI antithrombotic treatment management

Giuseppe Musumeci

READAPT survey - Results presentation

Dominick Angiolillo

Case presentation

David Erlinge

Recommendations and practice for patients with cardiogenic shock

David Erlinge

Clinical case conclusion - Patient peri-PCI antithrombotic treatment management

David Erlinge

Discussion and audience interaction
Session evaluation and key learnings

Davide Capodanno